Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Xencor, Inc.
Canadian Cancer Trials Group
University of Wisconsin, Madison
Abramson Cancer Center at Penn Medicine
Cancer Research UK
University Health Network, Toronto
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Baylor College of Medicine
Baylor College of Medicine
Cancer Research UK
Chinese University of Hong Kong
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)